Hyperfine, Inc.

NasdaqGM HYPR

Hyperfine, Inc. Price to Earnings Ratio (P/E) on February 06, 2025: -3.04

Hyperfine, Inc. Price to Earnings Ratio (P/E) is -3.04 on February 06, 2025, a -82.27% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Hyperfine, Inc. 52-week high Price to Earnings Ratio (P/E) is -1.29 on May 10, 2024, which is 57.51% above the current Price to Earnings Ratio (P/E).
  • Hyperfine, Inc. 52-week low Price to Earnings Ratio (P/E) is -3.04 on February 06, 2025, which is 0.00% below the current Price to Earnings Ratio (P/E).
  • Hyperfine, Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is -1.67.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
SV Wall Street
NasdaqGM: HYPR

Hyperfine, Inc.

CEO Ms. Maria Sainz
IPO Date Jan. 28, 2021
Location United States
Headquarters 351 New Whitfield Street
Employees 131
Sector Health Care
Industries
Description

Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. It offers Swoop Portable MR imaging system to address an unmet need in point-of-care medical imaging through a combination of hardware and software services. The company was incorporated in 2014 and is based in Guilford, Connecticut.

Similar companies

SRDX

Surmodics, Inc.

USD 34.06

0.62%

LIVN

LivaNova PLC

USD 49.95

-1.36%

IRMD

IRadimed Corporation

USD 61.36

-2.09%

ELMD

Electromed, Inc.

USD 34.30

-2.22%

APYX

Apyx Medical Corporation

USD 1.39

-6.08%

ITGR

Integer Holdings Corporation

USD 140.91

-1.01%

KIDS

OrthoPediatrics Corp.

USD 23.71

-3.85%

LUNG

Pulmonx Corporation

USD 6.43

4.55%

INGN

Inogen, Inc.

USD 10.84

-8.52%

OFIX

Orthofix Medical Inc.

USD 18.47

-2.99%

ANIK

Anika Therapeutics, Inc.

USD 17.79

-1.00%

NPCE

NeuroPace, Inc.

USD 13.66

-4.41%

StockViz Staff

February 7, 2025

Any question? Send us an email